GOVX - GeoVax Labs, Inc.
0.9292
-0.001 -0.151%
Share volume: 119,384
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$0.93
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 05-14-2024 | 08-06-2024 | 11-12-2024 | 03-27-2025 | 05-01-2025 | |
| Total revenue | 0.000 | 300.677 K | 2.789 M | 864.415 K | 1.637 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 300.677 K | 2.789 M | 864.415 K | 1.637 M | |
| inf% | 827.73% | -69.01% | 89.36% | |||
| Operating expenses | 5.883 M | 5.363 M | 8.644 M | 9.209 M | 7.042 M | |
| Selling general and admin | 1.457 M | 1.086 M | 1.241 M | 1.601 M | 1.687 M | |
| Research and development | 4.426 M | 4.277 M | 7.403 M | 7.608 M | 5.355 M | |
| Total expenses | 5.883 M | 5.363 M | 8.644 M | 9.209 M | 7.042 M | |
| -8.84% | 61.18% | 6.53% | -23.53% | |||
| Operating income | -5.883 M | -5.062 M | -5.855 M | -8.344 M | -5.405 M | |
| Ebit | -5.883 M | -5.062 M | -5.855 M | -8.344 M | -5.405 M | |
| Pretax income | -5.850 M | -5.064 M | -5.815 M | -8.263 M | -5.358 M | |
| -13.44% | 14.84% | 42.08% | -35.16% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -5.850 M | -5.064 M | -5.815 M | -8.263 M | -5.358 M | |
| 13.44% | -14.84% | -42.08% | 35.16% |
